Keywords: kosan, pivotal, ph, iii, tanespimycin, trial, starts

Kosan's pivotal Ph III tanespimycin trial starts recruiting

Article | 14 January 2008

Print This

The USA's Kosan Biosciences' TIME-1 trial, a pivotal Phase III study of tanespimycin as a potential treatment for multiple myeloma, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in